The Fellow on Call: The Heme/Onc Podcast cover image

Episode 076: Management of primary refractory diffuse large B-cell lymphoma (DLBCL)

The Fellow on Call: The Heme/Onc Podcast

00:00

Innovative Approaches in Managing Refractory DLBCL

This chapter delves into the management of primary refractory diffuse large B-cell lymphoma (DLBCL), advocating for CAR-T therapy in suitable patients. It highlights the role of bridging therapies, the leukapheresis process, and the necessity for meticulous post-infusion monitoring, while hinting at future discussions on relapse management and alternative therapies.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app